Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
10/2003
10/02/2003US20030187263 Viricides
10/02/2003US20030187262 Viricides, anticancer agents
10/02/2003US20030187258 Bactericides
10/02/2003US20030187060 Aminoalkenylbenzoyl-benzofuran or benzothiophene, method for preparing same and compositions containing same
10/02/2003US20030187053 Eating disorders; antilipemic agents; anticholesterol agents; cardiovascular disorders
10/02/2003US20030187043 Substituted n-benzoyl-n'(tetrazolylphenyl)-ureas and their use as pest control agents
10/02/2003US20030187033 Potassium channel modulators; cardiovascular disorders; antiarrhythmia agents
10/02/2003US20030187027 Dioxanes and uses thereof
10/02/2003US20030187024 Vision disorders; antiinflammatory agents; autoimmune disease; anticancer qgents; skin disorders
10/02/2003US20030187023 Sulfone derivatives, process for their production and use thereof
10/02/2003US20030187022 Pain management; analgesics
10/02/2003US20030187021 Treatment of CNS disorders using CNS target modulators
10/02/2003US20030187020 Chemical compounds
10/02/2003US20030187009 Analgesics, diarrhea, anticonvulsants, antitussive agents or drug abuse therapy
10/02/2003US20030187007 Inhibitors of protein kinase for the treatment of disease
10/02/2003US20030186996 Angiogenesis inhibitors
10/02/2003US20030186995 Substituted bicyclic derivatives useful as anticancer agents
10/02/2003US20030186981 Antiinflammatory agents; osteoporosis; rheumatic diseases; autoimmune diseases
10/02/2003US20030186976 Benzofurylpyrone derivatives
10/02/2003US20030186975 Coumarin derivatives with comt inhibiting activity
10/02/2003US20030186967 Anticancer agents; antiinflammatory agents; bone disorders; viricides
10/02/2003US20030186964 Piperdines for use as orexin receptor antagonists
10/02/2003US20030186963 Central nervous system disorders; cardiovascular disorders
10/02/2003US20030186962 Cysteine protease inhibitors
10/02/2003US20030186961 Central nervous system disorders; vision defects
10/02/2003US20030186958 Viricides, vision defects, oral diseases, antiarthritic agents, multiple sclerosis, anticancer agents
10/02/2003CA2761440A1 Fredericamycin derivatives
10/02/2003CA2480219A1 Pharmaceutical compositions comprising a benzofuran derivative and their use for the treatment of attention deficit/hyperactivity disorder
10/02/2003CA2479150A1 Heteroaromatic urea derivatives as vr-1 receptor modulators for treating pain
10/02/2003CA2477771A1 Phthalimido derivatives as inhibitors of monoamine oxidase b
10/02/2003CA2477091A1 1,2-dihydropyrazol-3-ones as cytokine mediators
10/01/2003EP1347968A1 Lfa-1 antagonist compounds
10/01/2003EP1347967A1 Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists
10/01/2003EP1347959A1 Indole derivatives as ligands of thyroid receptors
10/01/2003EP1347957A1 Delta 1-pyrrolines used as pesticides
10/01/2003EP1347950A1 Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of gamma-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses
10/01/2003EP1347784A2 Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation
10/01/2003EP1347751A2 Methods of treating bone cancer and the pain associated therewith using endothelin antagonists
10/01/2003EP1200423B1 Substituted phenyl uracils
10/01/2003EP1089996B1 Paroxetine methanesulfonate acetonitrile solvate 1:1
10/01/2003EP1000029B1 (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders
10/01/2003EP0944595B1 5-cyclo indole compounds as 5-ht1d receptor ligands
10/01/2003EP0891331B1 N-(2 oxoacetyl or sulphonyl)-pyrrolidine/piperidine-2-carboxylic acid derivatives with improved multi-drug resistance activity
10/01/2003EP0882711B1 Indole derivatives and rooting inducers comprising the same as the active ingredient
10/01/2003CN1446220A Method for the production of imidazo-[1,2-c] [2,3]-benzodiazepines and intermediates in production thereof
10/01/2003CN1446213A Medicinal compositions containing propenone derivatives
10/01/2003CN1446212A Quinoline derivatives having VEGF inhibiting activity
10/01/2003CN1446202A 2-aminopyridine compounds and use thereof as drugs
10/01/2003CN1446048A N-phenyl-4-(4-pyridyl)-2-pyrimidineamine derivatives
10/01/2003CN1445222A Benzofuran category compound, its preparing method and usage
10/01/2003CN1122668C Epothilone derivatives and their preparation method and their use as antitumor agents
10/01/2003CN1122666C New 2,3-dioxide indanol compounds, process for their preparation and pharmaceutical compositions containing them
10/01/2003CN1122442C Fungicidal mixtures
09/2003
09/30/2003US6627767 Controlling cellular metabolism
09/30/2003US6627651 Exhibiting preventive and therapeutic effects against HIV infectious diseases wherein R1 is an optionally substituted five- or six-membered ring group; X1 is a free valency or the like; W is a divalent group and inhibitors of HIV (human
09/30/2003US6627650 An isomer thereof, or an addition salt thereof with a pharmaceutically acceptable acid or base. Medicinal products containing the same which are useful as anti- cancer agents.
09/30/2003US6627645 Muscarinic agonists
09/30/2003US6627644 4-piperidinyl alkyl amine derivatives as muscarinic receptor antagonists
09/30/2003US6627634 Antitumor agents, treatment of the lungs and respiratory tract
09/30/2003US6627629 Useful for the treatment or prevention of asthma and other allergic diseases.
09/30/2003US6627624 Agonists, antagonists or inverse agonists for GABAa brain receptors or prodrugs of agonists, antagonists or inverse agonists for GABAa brain receptors, and are therefore useful in the diagnosis and treatment of anxiety, Down Syndrome,
09/30/2003US6627611 C-glycosides and preparation of thereof as antidiabetic agents
09/30/2003US6627111 Reduced pH sensitivity and enhanced stability to protonation; efficiency
09/30/2003CA2028650C Preparation of cis-2-(1h-1,2,4-triazol-1-ylmethyl)-2-(halophenyl)-3-(halophenyl)oxirane
09/25/2003WO2003078627A2 A building block capable of functional entity transfer to nucleophil
09/25/2003WO2003078626A2 A building block capable of transferring a functional entity
09/25/2003WO2003078625A2 An improved method for synthesising templated molecules
09/25/2003WO2003078446A2 A building block forming a c-c or a c-hetero atom bond upon reaction
09/25/2003WO2003078445A2 A building block forming a c=c double bond upon reaction
09/25/2003WO2003078438A1 Carbamates as hiv protease inhibitors
09/25/2003WO2003078421A1 Piperidine derivatives useful as modulators of chemokine receptor activity
09/25/2003WO2003078420A2 Process for making chiral 1,4-disubstituted piperazines
09/25/2003WO2003078417A1 Process for synthesizing chiral n-aryl piperazines
09/25/2003WO2003078416A1 Therapeutic ion channel blocking agents and methods of use thereof
09/25/2003WO2003078403A2 Derives d’aminoindazoles comme inhibiteurs de proteine-kinase
09/25/2003WO2003078402A1 Indazoles substituted with an anti-cancerous activity
09/25/2003WO2003078398A1 NON-PEPTIDE GnRH ANTAGONISTS
09/25/2003WO2003078396A1 Preparation of n1-(2’-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines
09/25/2003WO2003078050A2 A building block forming a c-c bond upon reaction
09/25/2003WO2003077921A1 Azinylaminoazoles as inhibitors of protein kinases
09/25/2003WO2003077918A1 Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5
09/25/2003WO2003077914A1 N3 alkylated benzimidazole derivatives as mek inhibitors
09/25/2003WO2003077913A1 Peptide deformylase inhibitors
09/25/2003WO2003077910A1 Methods of treatment with selective ep4 receptor agonists
09/25/2003WO2003077907A1 Azetidine derivatives as ccr-3 receptor antagonists
09/25/2003WO2003077656A1 4-aminopyrimidines and their use for the antimicrobial treatment of surfaces
09/25/2003WO2002100829A9 Process for the preparation of paroxetine substantially free of alkoxy impurities
09/25/2003WO2002060392A3 Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
09/25/2003WO2002036573B1 8- substituted-2, 6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents
09/25/2003US20030181725 Method of producing amorphous paroxetine hydrochloride
09/25/2003US20030181718 Process for synthesis of heteroaryl-substituted urea compounds useful as antiinflammatory agents
09/25/2003US20030181716 Novel azepane derivatives
09/25/2003US20030181502 Methods of treating sepsis
09/25/2003US20030181497 Heterocyclic acridone inhibitors of IMPDH enzyme
09/25/2003US20030181490 For therapy and prophylaxis of acquired immune deficiency syndrome (AIDS), or ARC
09/25/2003US20030181486 Novel use of(r) -(-) -2-[5-(4-fluorophenyl)-3- pyridylmethylaminomethy]-chromane and its physiologically acceptable salts )
09/25/2003US20030181472 Inflammation modulators
09/25/2003US20030181465 Pyrimidines as novel openers of potassium ion channels
09/25/2003US20030181456 Heterocyclic amines used as antiemetics for prophylaxis of irritable bowel syndrome constipation, diarrhea, dyspepsia, nausea or vomiting
09/25/2003US20030181446 Novel N-acylated heterocycles
1 ... 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 ... 694